Fig. 01 -

EU Perspective

Fig. 02 -

Targeting COPD Patients

Fig. 03 -

Unstable Post AECOPD vs Stable COPD

Fig. 04 -

Unstable Post AECOPD

Fig. 05 -

Outcome after AECOPD

Fig. 06 -

Chu et al, Thorax, 2004

Fig. 07 -

UK Data

Fig. 08 -

UK Survival AECOPD

Fig. 09 -

Post AHRF AECOPD

Fig. 10 -

Post AHRF AECOPD who remain hypercapnic

Fig. 11 -

Long term follow up

Fig. 12 -

An economic analysis

Fig. 13 -

Pilot trial

Fig. 14 -

Primary Outcome

Fig. 15 -

23 NIV / 23 CPAP

Fig. 16 -

Absolute Risk Reduction

Fig. 17 -

No difference in mortality

Fig. 18 -

Long-term non-invasive ventilation

Fig. 19 -

Time to clinical worsening

Fig. 20 -

Outcome Data

Fig. 21 -

Chronic Stable COPD Patients

Fig. 22 -

Thomas Kohnlein, et al

Fig. 23 -

Advanced disease state

Fig. 24 -

HMV vs Standard Treatment

Fig. 25 -

5 : 1

Fig. 26 -

Emergency admission rate

Fig. 27 -

Readmission Frequency

Fig. 28 -

Dutch Study

Fig. 29 -

Outcome

Fig. 30 -

Conclusion

Fig. 31 -

Target population

Fig. 32 -

Affiliates

Fig. 33 -

Pictures